BioTrinity 2019 will take place in London on April 29th – May 1st and will include revisions made on the basis of feedback from delegates at BioTrinity 2018
and innovations from the OBN Team. Our aim is to continue to provide a unique opportunity for interactions between investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to strike deals and grow their networks.
BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors.
10% discount on registration for members.